Lipoprotein (a)[Lp (a)], is present only in humans, Old World nonhuman primates, and the
European hedgehog. Lp (a) has many properties in common with low-density lipoprotein …

Abstract Lipoprotein (a)[Lp (a)] is an established cardiovascular risk factor, and growing
evidence indicates its causal association with atherosclerotic disease because of the …

Plasma lipoprotein (a)[Lp (a)], a low density lipoprotein particle with an attached
apolipoprotein (a)[apo (a)], varies widely in concentration between individuals. These …

Summary Apolipoprotein (a)[apo (a)] exhibits a genetic size polymorphism explaining about
40% of the variability in lipoprotein (a)[Lp (a)] concentration in Tyroleans. Lp (a) …

Objective: We sought to investigate the changes in circulating serum lipids and lipoproteins,
including lipoprotein (a), and low-density lipoprotein size in women during normal …

BACKGROUND Lipoprotein (a)[Lp (a)] is an atherogenic particle that structurally resembles
a low density lipoprotein (LDL) particle but contains a molecule of apolipoprotein (a) …

Objective.—To examine the relationship between elevated levels of lipoprotein (a)[Lp (a)]
and coronary heart disease (CHD) risk in a prospective study. Design.—Nested case-control …

Lipoprotein (a)[Lp (a)] is a cholesterol-rich lipoprotein that is distinguished by its content of a
glycoprotein called apolipoprotein (a)[apo (a)]. Apo (a) varies in size among individuals …

Abstract Lipoprotein (a)[Lp (a)] is a quantitative trait in human plasma. Lp (a) consists of a
low-density lipoprotein and the plasminogen-related apolipoprotein (a)[apo (a)]. The apo (a) …

Background: Major risk factors explain much of the excess risk for coronary heart disease
produced by diabetes, but nontraditional factors may also relate to incident coronary heart …